ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,272Medicare Part D Prescriptions Filled, Including Refills

Rank: 107 out of 682

$907K Total Retail Price of All Prescriptions

Rank: 128 out of 682

376 Patients Receiving at Least One Drug in Part D
85%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 14,312 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 590 513 1 5
HYDROCODONE-ACETAMINOPHEN 513 343 S3 2 1
AMLODIPINE BESYLATE 452 413 3 6
LEVOTHYROXINE SODIUM 429 390 4 3
LISINOPRIL 424 346 5 2
PRAVASTATIN SODIUM 411 369 6 15
BISOPROLOL FUMARATE 399 352 7 142
HYDROCHLOROTHIAZIDE 367 314 8 12
GABAPENTIN 366 291 9 9
SIMVASTATIN 323 289 10 4
SERTRALINE HCL 298 250 11 24
FUROSEMIDE 290 253 12 7
POTASSIUM CHLORIDE 279 218 13 14
ISOSORBIDE MONONITRATE ER 254 227 14 31
METFORMIN HCL 249 184 15 8
ATENOLOL 245 211 16 18
CARVEDILOL 244 219 17 23
LOSARTAN POTASSIUM 238 221 18 20
GLIMEPIRIDE 199 159 19 43
FAMOTIDINE 189 165 20 99
METOPROLOL TARTRATE 186 158 21 10
DONEPEZIL HCL 177 177 22 30
METFORMIN HCL ER 166 142 23 68
WARFARIN SODIUM 164 154 24 13
FLUTICASONE PROPIONATE 164 123 24 36
CITALOPRAM HBR 162 113 26 17
FOSINOPRIL SODIUM 155 155 27 275
ADVAIR DISKUS 144 125 28 47
METOPROLOL SUCCINATE 141 121 29 16
ATORVASTATIN CALCIUM 140 116 30 11
NAMENDA 140 140 30 41
CLOPIDOGREL 138 88 32 25
NEXIUM 137 68 33 19
PAROXETINE HCL 131 131 34 53
TAMSULOSIN HCL 130 117 35 33
DIGOXIN 126 120 36 46
EXELON 122 122 37 104
FINASTERIDE 119 103 38 131
ALLOPURINOL 118 101 39 32
LIDODERM 114 106 40 134
PLAVIX 109 87 41 35
SPIRIVA 107 88 42 49
TERAZOSIN HCL 107 82 42 171
VOLTAREN 105 105 44 284
HYDRALAZINE HCL 104 74 45 74
POLYETHYLENE GLYCOL 3350 103 90 46 44
DILTIAZEM 24HR ER 97 71 47 162
SINGULAIR 96 59 48 63
LANTUS 96 75 48 55
FLUOXETINE HCL 94 43 50 60
ROPINIROLE HCL 88 63 51 71
SYNTHROID 86 75 52 59
PREDNISONE 85 80 53 40
DOXYCYCLINE HYCLATE 85 71 53 137
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 74 55 34
TRAMADOL HCL 82 72 55 26
LOSARTAN-HYDROCHLOROTHIAZIDE 74 62 57 56
AMLODIPINE BESYLATE-BENAZEPRIL 71 71 58 77
BISOPROLOL-HYDROCHLOROTHIAZIDE 70 66 59 147
NIASPAN 70 43 59 133
METOCLOPRAMIDE HCL 70 70 59 111
NAPROXEN 68 47 62 97
LOVAZA 67 31 63 106
INSULIN SYRINGE 67 63 63 75
JANUVIA 66 40 65 62
CALCITONIN-SALMON 66 66 65 269
DIOVAN 66 66 65 42
PROMETHAZINE HCL 66 32 R 65 54
ALENDRONATE SODIUM 65 65 69 37
LYRICA 65 35 69 78
MONTELUKAST SODIUM 65 44 69 112
KLOR-CON 10 63 59 72 148
CARBIDOPA-LEVODOPA 62 56 73 121
TRAZODONE HCL 61 33 74 38
SPIRONOLACTONE 61 49 74 64
NYSTATIN 60 50 76 95
PRAMIPEXOLE DIHYDROCHLORIDE 60 30 76 190
CYCLOBENZAPRINE HCL 59 0 R 78 65
NOVOLOG 58 48 79 129
PROAIR HFA 58 51 79 45
CIPROFLOXACIN HCL 54 42 81 58
PEN NEEDLE 53 33 82 159
LANSOPRAZOLE 50 31 83 85
DILTIAZEM 24HR CD 50 50 83 123
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.